MicroRNA-18a enhances the radiosensitivity of cervical cancer cells by promoting radiation-induced apoptosis

Oncology Reports

Volumn 33, Issue 6, 2015, Pages 2853-2862

  Liu, Sha ^a   Pan, Xiaofen ^a   Yang, Qin ^a   Wen, Lu ^a   Jiang, Yao ^a   Zhao, Yingchao ^a   Li, Guiling ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; ATM; Cervical cancer; miR 18a; Radiosensitivity; Radiotherapy

Indexed keywords

ATM PROTEIN; DOUBLE STRANDED DNA; HISTONE H2AX; MICRORNA; MICRORNA 18A; UNCLASSIFIED DRUG; MIRN18A MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; ATM GENE; CANCER RADIOTHERAPY; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; GAMMA H2AX GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MTT ASSAY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; GENETICS; HELA CELL LINE; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; TUMOR CELL LINE; UTERINE CERVICAL NEOPLASMS;

APOPTOSIS; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICRORNAS; RADIATION TOLERANCE; UTERINE CERVICAL NEOPLASMS;

EID: 84928910771     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3929     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Krieger N, Bassett MT and Gomez SL: Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet 379: 1391-1392, 2012.
3. Rogers L, Siu SS, Luesley D, Bryant A and Dickinson HO: Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database Syst Rev 5: CD007583, 2012.
4. Yuan W, Xiaoyun H, Haifeng Q, Jing L, Weixu H, Ruofan D, Jinjin Y and Zongji S: MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis. Int J Med Sci 11: 691-696, 2014.
5. Metheetrairut C and Slack FJ: MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev 23: 12-19, 2013.
6. Bernstein E, Caudy AA, Hammond SM and Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366, 2001.
7. Hummel R, Hussey DJ and Haier J: MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 46: 298-311, 2010.
8. Zhang B, Wang Q and Pan X: MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210: 279-289, 2007.
9. Ke G, Liang L, Yang JM, Huang X, Han D, Huang S, Zhao Y, Zha R, He X and Wu X: MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene 32: 3019-3027, 2013.
10. Chen HM, Hsu JH, Liou SF, Chen TJ, Chen LY, Chiu CC and Yeh JL: Baicalein, an active component of Scutellaria baicalensis Georgi, prevents lysophosphatidylcholine-induced cardiac injury by reducing reactive oxygen species production, calcium overload and apoptosis via MAPK pathways. BMC Complement Altern Med 14: 233, 2014.
11. Bourton EC, Plowman PN, Smith D, Arlett CF and Parris CN: Prolonged expression of the ã-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer 129: 2928-2934, 2011.
12. Ohba S, Mukherjee J, See WL and Pieper RO: Mutant IDH1?driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance. Cancer Res 74: 4836-4844, 2014.
13. Song L, Lin C, Wu Z, Gong H, Zeng Y, Wu J, Li M and Li J: miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One 6: e25454, 2011.
14. Wu CW, Dong YJ, Liang QY, He XQ, Ng SS, Chan FK, Sung JJ and Yu J: MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. PLoS One 8: e57036, 2013.
15. Shiloh Y and Ziv Y: The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14: 197-210, 2013.
16. Borgstahl GE, Brader K, Mosel A, Liu S, Kremmer E, Goettsch KA, Kolar C, Nasheuer HP and Oakley GG: Interplay of DNA damage and cell cycle signaling at the level of human replication protein A. DNA Repair (Amst) 21: 12-23, 2014.
17. Bakkenist CJ and Kastan MB: DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506, 2003.
18. Nakano T, Kato S, Ohno T, Tsujii H, Sato S, Fukuhisa K and Arai T: Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 103: 92-101, 2005.
19. Qi L, Xing LN, Wei X and Song SG: Effects of VEGF suppression by small hairpin RNA interference combined with radiotherapy on the growth of cervical cancer. Genet Mol Res 13: 5094-5106, 2014.
20. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006.
21. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
22. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
23. Tao J, Wu D, Li P, Xu B, Lu Q and Zhang W: microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells. Mol Med Rep 5: 167-172, 2012.
24. Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS and Chen PJ: MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 136: 683-693, 2009.
25. Fujiya M, Konishi H, Mohamed Kamel MK, Ueno N, Inaba Y, Moriichi K, Tanabe H, Ikuta K, Ohtake T and Kohgo Y: microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1. Oncogene 33: 4847-4856, 2014.
26. Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, et al: miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 34: 415-425, 2013.
27. Symington LS and Gautier J: Double-strand break end resection and repair pathway choice. Annu Rev Genet 45: 247-271, 2011.
28. Valdiglesias V, Giunta S, Fenech M, Neri M and Bonassi S: γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res 753: 24-40, 2013.
29. Kinner A, Wu W, Staudt C and Iliakis G: Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res 36: 5678-5694, 2008.
30. Hu H, Du L, Nagabayashi G, Seeger RC and Gatti RA: ATM is downregulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA 107: 1506-1511, 2010.
31. Yan D, Ng WL, Zhang X, Wang P, Zhang Z, Mo YY, Mao H, Hao C, Olson JJ, Curran WJ, et al: Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 5: e11397, 2010.
32. Ng WL, Yan D, Zhang X, Mo YY and Wang Y: Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. DNA Repair (Amst) 9: 1170-1175, 2010.
33. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E and Slack FJ: MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67: 11111-11116, 2007.
34. Josson S, Sung SY, Lao K, Chung LW and Johnstone PA: Radiation modulation of microRNA in prostate cancer cell lines. Prostate 68: 1599-1606, 2008.
35. Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 10: 367, 2010.
36. Xue Q, Sun K, Deng HJ, Lei ST, Dong JQ and Li GX: Anti-miRNA-221 sensitizes human colorectal carcinoma cells to radiation by upregulating PTEN. World J Gastroenterol 19: 9307-9317, 2013.
37. Huang S, Li XQ, Chen X, Che SM, Chen W and Zhang XZ: Inhibition of microRNA-21 increases radiosensitivity of esophageal cancer cells through phosphatase and tensin homolog deleted on chromosome 10 activation. Dis Esophagus 26: 823-831, 2013.
38. Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P and Hu W: microRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep 23: 997-1003, 2010.
39. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134, 2007.
40. Wu Y, Liu GL, Liu SH, Wang CX, Xu YL, Ying Y and Mao P: MicroRNA-148b enhances the radiosensitivity of non-Hodgkin's lymphoma cells by promoting radiation-induced apoptosis. J Radiat Res (Tokyo) 53: 516-525, 2012.
41. Arora H, Qureshi R, Jin S, Park AK and Park WY: miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1. Exp Mol Med 43: 298-304, 2011.
42. Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM and Slack FJ: Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther 12: 908-914, 2011.
43. Zhang JX, Qian D, Wang FW, Liao DZ, Wei JH, Tong ZT, Fu J, Huang XX, Liao YJ, Deng HX, et al: MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. Cancer Lett 329: 91-98, 2013.